MedPath

Intra Amniotic Injection of DIGOXIN for Feticide in Second Trimester Termination of Pregnancy

Phase 3
Conditions
Arrhythmia
Hypotension
ECG Changes
Interventions
Drug: Intra-amniotic injection of DIGOXIN
Registration Number
NCT01951079
Lead Sponsor
Meir Medical Center
Brief Summary

In second trimester abortion above 22 weeks the investigators usually inject intra-cardiac Kcl for feticide. Digoxin intra-amniotic injection has been described in the literature in doses of 1-1.5 mg. with a success rate of about 80%, and up to 24 weeks. Our aim in this study is to investigate the safety and success rate of 1.5-2 mg. digoxin, intra-amniotic up to 30 weeks pregnancy .

Detailed Description

* The digoxin will be injected intra-amniotic with U.S guided, trying to avoid any placental passage or intravascular injection /

* Any patient will have prior to the procedure a full examination including E.C.G and cardiac clearance.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • healthy women with no medical, cardiac, hypertension, liver or renal problems - pregnant in their 20-30 week gestation,
  • that need to have abortion due to fetal anomalies or any other reason
  • need to have feticide prior to the procedure
Exclusion Criteria
  • any patient with medical problem that may be a contra-indication to Digoxin
  • cardiac problems,
  • prior cardiac surgery,
  • liver or kidney disease,
  • hyper tension etc.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
second trimester abortion , feticideIntra-amniotic injection of DIGOXINall patients admitting to second trimester abortion above 22 weeks will be injected intra-amniotic DIGOXIN for feticide .
Primary Outcome Measures
NameTimeMethod
Efficiency of intra-amniotic Digoxin injection for second trimester feticidea year

To measure the Success rate of intra-amniotic Digoxin injection for feticide prior to second trimester abortion

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Sapir medical center

🇮🇱

Kefar-saba, Israel

Dr. Zvi Klein

🇮🇱

Kefar-saba, Israel

© Copyright 2025. All Rights Reserved by MedPath